CDA and cancer: Gemcitabine inactivation is facilitated by cytidine deaminase (CDA) which converts gemcitabine to 2′,2′-difluorodeoxyuridine and cancer patients with lower serum levels of CDA show a significantly longer survival than patients with high CDA levels [11,4].